On January 1, 2018, the Physician Clinical Registry Coalition submitted a comment letter on the CY 2018 Updates to the Quality Payment Program final rule. The letter emphasizes concerns regarding the lack of transparency and consistency in the QCDR measures review process. Coalition members experienced the following during the QCDR measure review process for the 2018 performance period: impractical timelines, rejection of measures without regard for clinical rationale, inconsistent feedback and unclear rejection methodology or consolidation rationale, and disjointed communication and review of measures. The letter requests that CMS does not align QCDR measure approval with the Call for Quality Measures process or create more stringent standards for QCDR measures. We also asked CMS to grant measures with high performance 7 points in the 2018 performance period and define its policy for placing QCDRs on probation or suspension for data inaccuracies and errors.
Click here to read the full letter.